COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector

NCT04481529 | Unknown

• 1 other identifier: 87RI20_0049/SEROCO
• Study Type: observational
• Target: 1,576
• Locations: 1 country
• Sites: 4

Brief Summary

Hospital staff, on the front line in the COVID-19 crisis, have many questions about the risk that they have been infected with this potentially fatal virus. These questions of course primarily concern caregivers working in sectors dedicated to COVID-19 patients, whether they are resuscitating or not, but also those in non-COVID-19 sectors, or even staff without direct contact with patients. In addition, depending on the suddenness and intensity of this "COVID-19 wave", these personnel have been more or less trained and sometimes exposed due to the dire lack of protective equipment. In some countries such as Great Britain, this has resulted in significant absenteeism, a source of deepening the shortage of caregivers. This proportion of contaminated caregivers has not been evaluated on the whole of French territory. Studies from other countries suggest figures ranging from 1.5% in China to 20% in Italy. It is therefore impossible to rely on such variable data to have a reliable estimate. Since june 2020, all staff in French health establishments could benefit a serological test. Thus, in this epidemiological study, we propose to rely on this institutional serological screening to describe the link between seroconversion of hospital staff, regional intensity of the epidemic, and sectors of activity (COVID-19 sectors, non-COVID-19 caregivers , non-COVID-19 non-caregivers.

Conditions

Infection Viral

Outcome Measures

Primary Outcomes (1)

• Number of subjects with a COVID-19 seroconversion

  Number of subjects with a COVID-19 seroconversion fixed by the presence of IgG + in serology according to the service (COVID19 +, COVID19- caregiver, COVID- non-caregiver).

  through study completion, an average of 5 month

Interventions

Health Questionnaire OTHER

Completion of a short questionnaire noting the result of the serology and looking for elements in favor of exposure to the virus, whether professional or extra-professional.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Hospital staff

You may qualify if:

• Hospital staff from Argenteuil, Belfort, Dijon and Limoges hospitals.
• Age ≥ 18 years old
• Participation agreement

You may not qualify if:

• Protected persons
• Refusal of participation

Sponsors & Collaborators

• University Hospital, Limoges: lead

Study Sites (4)

CH Argenteuil - Service de Réanimation

Argenteuil, 95107, France

Location

Ch Belfort

Belfort, 90000, France

Location

CHU Dijon - Serve de Réanimation

Dijon, 21079, France

Location

CHU de Limoges

Limoges, France

Location

MeSH Terms

Conditions

Virus Diseases

Interventions

Patient Health Questionnaire

Condition Hierarchy (Ancestors)

Infections

Intervention Hierarchy (Ancestors)

Surveys and Questionnaires; Data Collection; Epidemiologic Methods; Investigative Techniques; Psychological Tests; Behavioral Disciplines and Activities; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 20, 2020
• First Posted: July 22, 2020
• Study Start: July 29, 2020
• Primary Completion: December 15, 2020
• Study Completion: January 15, 2021
• Last Updated: January 13, 2021

Record last verified: 2020-11

Locations

FR (4)